See the DrugPatentWatch profile for Arazlo
Arazlo is a prescription topical medication used to treat acne vulgaris. Its active ingredient is tazarotene [1]. Tazarotene is a retinoid [1].
What is tazarotene's role in treating acne?
Tazarotene works by normalizing the differentiation of epithelial cells, reducing the formation of comedones and other acne lesions [1]. It is a topical retinoid that has anti-inflammatory and anti-acne properties [1].
What are the other components of Arazlo?
In addition to tazarotene, Arazlo contains inactive ingredients. These include carbomer homopolymer type B, glycerin, poloxamer 181, phenoxyethanol, propylene glycol, purified water, and sodium hydroxide [1].
How does Arazlo compare to other acne treatments?
Arazlo's active ingredient, tazarotene, is also found in other topical retinoid medications. The specific formulation and inactive ingredients can influence absorption, tolerability, and overall effectiveness [1]. Different retinoids and treatment regimens may be recommended based on the severity and type of acne [1].
When does Arazlo's patent expire?
Patent information for Arazlo can be found on DrugPatentWatch.com. DrugPatentWatch tracks patent expiry dates for various medications, which is relevant for understanding when generic versions might become available [2].